Active-Site Druggability of Carbapenemases and Broad-Spectrum Inhibitor Discovery

可药性 活动站点 小分子 对接(动物) 立体化学 药物发现 配体(生物化学) 化学 四唑 丝氨酸 组合化学 同源建模 生物 生物化学 酶 受体 护理部 基因 医学
作者
Nicholas J. Torelli,Afroza Akhtar,Kyle DeFrees,Priyadarshini Jaishankar,Orville A. Pemberton,Xiujun Zhang,Cody Johnson,Adam R. Renslo,Yu Chen
出处
期刊:ACS Infectious Diseases [American Chemical Society]
卷期号:5 (6): 1013-1021 被引量:31
标识
DOI:10.1021/acsinfecdis.9b00052
摘要

Serine and metallo-carbapenemases are a serious health concern due to their capability to hydrolyze nearly all β-lactam antibiotics. However, the molecular basis for their unique broad-spectrum substrate profile is poorly understood, particularly for serine carbapenemases, such as KPC-2. Using substrates and newly identified small molecules, we compared the ligand binding properties of KPC-2 with the noncarbapenemase CTX-M-14, both of which are Class A β-lactamases with highly similar active sites. Notably, compared to CTX-M-14, KPC-2 was more potently inhibited by hydrolyzed β-lactam products (product inhibition), as well as by a series of novel tetrazole-based inhibitors selected from molecular docking against CTX-M-14. Together with complex crystal structures, these data suggest that the KPC-2 active site has an enhanced ability to form favorable interactions with substrates and small molecule ligands due to its increased hydrophobicity and flexibility. Such properties are even more pronounced in metallo-carbapenemases, such as NDM-1, which was also inhibited by some of the novel tetrazole compounds, including one displaying comparable low μM affinities against both KPC-2 and NDM-1. Our results suggest that carbapenemase activity confers an evolutionary advantage on producers via a broad β-lactam substrate scope but also a mechanistic Achilles’ heel that can be exploited for new inhibitor discovery. The complex structures demonstrate, for the first time, how noncovalent inhibitors can be engineered to simultaneously target both serine and metallo-carbapenemases. Despite the relatively modest activity of the current compounds, these studies also demonstrate that hydrolyzed products and tetrazole-based chemotypes can provide valuable starting points for broad-spectrum inhibitor discovery against carbapenemases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
溧谦发布了新的文献求助10
刚刚
赘婿的应助被kiwi采纳,获得10
1秒前
嘟嘟完成签到,获得积分10
2秒前
3秒前
草莓完成签到 ,获得积分10
3秒前
3秒前
liyuanyuan发布了新的文献求助10
3秒前
3秒前
4秒前
完美世界的应助被luxiaoyu采纳,获得10
4秒前
长安望星河完成签到,获得积分10
5秒前
慕青的应助被无私的画笔采纳,获得10
5秒前
顺心觅风完成签到,获得积分20
5秒前
luoluoluoaaa123关注了科研通微信公众号
5秒前
6秒前
多喝水发布了新的文献求助20
6秒前
8秒前
9秒前
葳蕤2完成签到 ,获得积分10
9秒前
10秒前
外向凡松完成签到,获得积分10
10秒前
10秒前
天天向上的应助被liyuanyuan采纳,获得10
11秒前
水弘的应助被张三说刑法采纳,获得30
12秒前
kennrei完成签到,获得积分10
12秒前
科研通AI6.4的应助被qrj采纳,获得10
13秒前
13秒前
荀万声发布了新的文献求助10
14秒前
NexusExplorer的应助被Circle采纳,获得10
14秒前
Arrebol完成签到,获得积分10
14秒前
14秒前
多喝水完成签到,获得积分10
15秒前
luxiaoyu完成签到,获得积分10
15秒前
Dr大壮发布了新的文献求助10
15秒前
诶诶完成签到,获得积分10
15秒前
ding的应助被后笑晴采纳,获得10
16秒前
17秒前
科研通AI6.3的应助被浮云客采纳,获得10
17秒前
刘轩完成签到,获得积分10
17秒前
霸气雯发布了新的文献求助10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183601
求助须知:如何正确求助?哪些是违规求助? 9572875
关于积分的说明 21827816
捐赠科研通 7780716
什么是DOI,文献DOI怎么找? 3434031
关于科研通互助平台的介绍 2558197
邀请新用户注册赠送积分活动 2480485